Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
No, not real facts - it's real NONSENSE on all counts!
Continually repeating false statements does not eventually make them true.
Only thing being "EXPOSED" is the anxiety of the institutions who's trading positions make up the 4M share short interest.
This is MORE RIDICULOUS NONSENSE!!!
Guessing it was copied from CrapThatAintTrue.com
Doesn't say that! Your contention is still FALSE!
While 7 Institutions sold, 24 HAVE INITIATED NEW OWNERSHIP in NNVC STOCK, and 11 more have INCREASED their holdings!!!
Reporting only those who sold gives a totally false impression of the overall Institutional ownership situation.
http://www.nasdaq.com/symbol/nnvc/institutional-holdings/increased
48 Institutions Believe in NanoViricides: Hold $11M+ Stock!!!
These include: VANGUARD GROUP INC, GOLDMAN SACHS GROUP INC, GEODE CAPITAL MANAGEMENT LLC, SUSQUEHANNA INTERNATIONAL GROUP LLP, UBS AG, COLONY GROUP LLC, KCG HOLDINGS INC, AQR CAPITAL MANAGEMENT LLC, JANE STREET GROUP LLC, NORTHERN TRUST CORP, STALEY CAPITAL ADVISERS INC, and SCHWAB CHARLES INVESTMENT MANAGEMENT INC.
Apparently these institutions believe the science, and believe the risk reward ratio of an investment here argues for ownership!
http://www.nasdaq.com/symbol/nnvc/institutional-holdings
best to all!
So let's review the MISCHARACTERIZATION of the facts relative to institutional participation in NanoViricides stock.
The facts are, only a small portion of $11M of institutional ownership in NNVC stock is due to "index funds" relative to the Russell inclusion! In calendar Q1, there were 45 firms with ownership in NNVC BEFORE its inclusion in the Russell indices several weeks ago! In the first reporting period post Russell inclusion, there are now 48 institutional holders.
To suggest that ALL of the $11M in institutional participation is due to "index funds", thereby attempting to discount its significance, is a clear misrepresentation of the facts.
Reply of the week -- DEBUNKING all the ridiculous, fabricated points of the referenced post:
From BigKahuna -- 08/14/14 06:20:14 PM:
http://investorshub.advfn.com/boards/replies.aspx?msg=105310372
We have addressed your assumptions, each one by on, over and over and over again. Yet, these false assumption persist. None of your points remain uncontested, except maybe this particular list of those assumptions.
First, you falsely stated that the first test is tox. That's absolutely wrong on its face since the fist and most basic test is the in vitro proof of concept.
Second, in each of the tests I listed there is are toxicology elements where the test subject is examined for tissue interaction, damage or destruction. The gross histology for in vivo studies includes just that type of examination.
Third, if one insists that tox is the first and most basic, the most basic of the toxicology assays was conducted back in October of last year and reported last November. "These preliminary results support the Company’s positive findings in efficacy studies using animal models of different influenza A virus strains wherein no safety or toxicology concerns were observed. The Company has previously reported that our injectable FluCide drug candidate was highly effective in animal models of different influenza A virus strains." As it states earlier in the report, the findings confirm safety observed in the previous efficacy studies. It was in this non-GLP pre-tox study that they found out how much material they would need for the BASi GLP/GMP-like studies.
Fourth, what makes you think no one is giving NNVC's EbolaCide consideration or attention? Are you connected to the various agencies who seek a solution to the opresent and future outbreaks of Ebola?
Fifth, the original studies were shelved to focus on three other far more lucrative applications: Injectable FluCide, HIV-Cide and DengueCide. FluCide was pushed to the forefront. Interest in Ebola recently surged, and is likely to burn itself out for the current epidemic. But, with renewed interest comes pressure as well as incentive to restart the program. Why this is unreasonable to some is beyond my comprehension.
They were invited to ring the bell. That gets discussed following a PR that everyone who is anyone publicizes, including those few who are no one. All that other stuff, been talking about it for 9 years. Is it OK to talk about stuff other than "When is tox? Why no tox?" In case you missed it, NNVC has been talking about stuff other than ringing the bell, SA, and whatever that third thing refers to.
ACTUAL SHAREHOLDERS have NOT come to any bogus negative "realization" regarding this company. Any "smoke and mirrors" suggestion to the contrary is wishful thinking and gross misrepresentation.
As an ACTUAL SHAREHOLDER, my "hopes and dreams" have never been higher for NanoViricides! The company is just about to start the TOX studies which will pave the way for human clinical trials starting next year.
"Dark and murky characters" DO exist relative to NanoViricides, but they ARE NOT company officers, nor are they the actual shareholders.
The only thing "coming home to roost" will be the overwhelming financial losses of those associated with the four million share short interest which has been building in recent weeks.
ALMOST $18 MILLION SHORT INTEREST= HUGE PRICE SPIKE AHEAD!!!
HUGE 4M SHARE SHORT COVERING RALLY COMING!!!
More short interest means more fuel to the fire for the coming panic short covering rally!
best to all!
Institutions now hold $11M of NNVC stock!
best to all.
http://www.nasdaq.com/symbol/nnvc/institutional-holdings
No, actually, everything he wrote is objectively true.
Your statements and conclusions are completely FALSE!
Yes, considering there WASN'T one...
re: "fake tox": ABSOLUTELY RIDICULOUS!!!
Repeatedly misrepresenting facts does NOT eventually cause those misrepresentations to be come true.
Exposed? NONSENSE!!!!! They were LIBELED by a despicable coward.
Goldman Sachs was not "REQUIRED" to invest hundreds of thousands of dollars in NanoViricides stock. AND THEY WOULD NOT HAVE except for their assessment that the risk reward was favorable.
Please... I prefer reality.
NO HARM??? How about a 50% collapse in share price on huge volume? How about the harm to investors who got stopped out of their positions for big losses based on a libelous, wholly contrived and malicious article published by a self-proclaimed short seller?
NO HARM????? Seriously...
MORE NONSENSE!!! It was a hearing attempting to force SA to disclose the name of the author. Nothing more. It was in no way a validation of the lies put forth in the article.
Everyone knows better. Your post is not in any sense accurate.
YES, credible medical/biotech analysts HAVE looked at the science AND thought it was legit!!!
48 Institutions Believe in LEGITIMACY: Hold $11M+ Stock!!!
These include: VANGUARD GROUP INC, GOLDMAN SACHS GROUP INC, GEODE CAPITAL MANAGEMENT LLC, SUSQUEHANNA INTERNATIONAL GROUP LLP, UBS AG, COLONY GROUP LLC, KCG HOLDINGS INC, AQR CAPITAL MANAGEMENT LLC, JANE STREET GROUP LLC, NORTHERN TRUST CORP, STALEY CAPITAL ADVISERS INC, and SCHWAB CHARLES INVESTMENT MANAGEMENT INC.
Apparently these institutions believe the science, and believe the risk reward ratio of an investment here argues for ownership!
http://www.nasdaq.com/symbol/nnvc/institutional-holdings
48 Institutions Believe in NanoViriciedes: Hold $11M+ Stock!!!
These include: VANGUARD GROUP INC, GOLDMAN SACHS GROUP INC, GEODE CAPITAL MANAGEMENT LLC, SUSQUEHANNA INTERNATIONAL GROUP LLP, UBS AG, COLONY GROUP LLC, KCG HOLDINGS INC, AQR CAPITAL MANAGEMENT LLC, JANE STREET GROUP LLC, NORTHERN TRUST CORP, STALEY CAPITAL ADVISERS INC, and SCHWAB CHARLES INVESTMENT MANAGEMENT INC.
Apparently these institutions believe the science, and believe the risk reward ratio of an investment here argues for ownership!
http://www.nasdaq.com/symbol/nnvc/institutional-holdings
best to all!
More ridiculous nonsense - I prefer reality!
NanoViricides has moved from a Poink Sheet company, to a Bulletin Board company, AN NOW IS AN NYSE MKT LISTED COMPANY! They have $40M in the bank, no debt, and are just about to initiate their TOX study in support of Human Clinical Trials likely to begin next year.
And today they RANG THE OPENING BELL ON THE FLOOR OF THE NYSE!
It looks like the market understands that this company has HUGE potential, and that their patented drugs will likely become for viral disease what the discovery of Penicillin was to bacterial disease some 90 years ago.
There was no "fluffy" PR. That's ridiculous.
YOU BET!!!!! CNBC this morning at 9:29 ET
ALMOST $18 MILLION SHORT INTEREST= HUGE PRICE SPIKE AHEAD!!!
HUGE 4M SHARE SHORT COVERING RALLY COMING!!!
More short interest means more fuel to the fire for the coming panic short covering rally!
best to all!
It'll be fun observing just how far the short interest in this stock goes before... being forced to cover at a huge loss!!!
They are trying to get rich of the backsides of the shareholders is what it looks like to me.
More nonsense. Simply not true.
Of course they work. People ignore the science, and ignore the broad participation of reputable organizations with this company at their own peril.
Ridiculous nonsense!
Ridiculous.
WE CLOSED 1.5% HIGHER ON THE DAY!!! On FOUR TIMES AVERAGE DAILY VOLUME!!!
No, no one is "laughing" at Ebola.
But, those investors who have a negative opinion of this company expressed through their trading positions have reason to be very scared... $18M short interest in a company like this is dry tinder ready to burst into flames.
best to all.
Yes, we also had the CEO stating emphatically in an email that they "WILL NOT delay the start of the tox studies"!
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=104959756
best to all.
NNVC CLOSED UP 1.5% ON THE DAY!!!
And THAT on FOUR TIMES AVERAGE VOLUME!!!
That's utter nonsense! No such thing happened today!
We closed up on volume that was four times average daily.
48 Institutions Believe in LEGITIMACY: Hold $11M+ Stock!!!
These include: VANGUARD GROUP INC, GOLDMAN SACHS GROUP INC, GEODE CAPITAL MANAGEMENT LLC, SUSQUEHANNA INTERNATIONAL GROUP LLP, UBS AG, COLONY GROUP LLC, KCG HOLDINGS INC, AQR CAPITAL MANAGEMENT LLC, JANE STREET GROUP LLC, NORTHERN TRUST CORP, STALEY CAPITAL ADVISERS INC, and SCHWAB CHARLES INVESTMENT MANAGEMENT INC.
Apparently these institutions believe the science, and believe the risk reward ratio of an investment here argues for ownership!
http://www.nasdaq.com/symbol/nnvc/institutional-holdings
best to all!
I'M NEVER WRONG PREDICTING SUCCESS OF A BIOTECH!!!
And NanoViricides will be a HUGE SUCCESS in coming months and years!
I'm never wrong! NEVER!!!
best to all.
re: West Africa: A 5% pop on almost 3 times average daily volume BY NOON, the market apparently isn't "annoyed", and apparently doesn't think there's any "exploitation" going on... at least not on the part of the company, NanoViricides.
best to all.
No, it absolutely doesn't, and here's why.
FluCide TOX has been delayed because of the large quantity of drug materials needed to this study. Essentially, the task of the TOX is to find the lethal level of a basically non-toxic substance (the NNVC drug). The company underestimated the quantity of drug needed, so TOX has been delayed. Maybe they needed to make enough to drown the animals...
However, the amount of materials required for a "standard" drug development program is far, far less. The new Ebola program will be looking for efficacy of the drug, not lethality of the drug. Quantities of drug materials will be FAR, FAR less than that required for TOX.
It's reasonable to assume the company will need to provide ALL of the FluCide drug material to the TOX testing agency up front, at the beginning of the study. Therefore, once that starts, the TWO labs that NanoViricides now owns and operates will no longer been needed to produce FluCide in the near term, so their production capacity can be shifted to Ebola with no subsequent delay in FluCide progress. Further, once TOX starts and is in the hands of the 3rd party, the staff of NNVC likely could focus temporarly on Ebola without negatively impacting the FluCide program.
best to all.
I think you're spot on with 4.77 area, or even a touch lower!
There's a mildly declining intermediate term resistance line with two points, one from an intraday high on June 24th of 4.77 and the other an intraday high from July 17th of 4.73. That line today crosses below both those points, maybe around 4.65 or so.
A break and close above that trend line definitely would suggest a move higher, at least to the $5 area to test prices from late last year, and hopefully above!
best to all.